Patents by Inventor Carsten Dietrich

Carsten Dietrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11920201
    Abstract: Provided herein are methods of determining one or more modification(s) of the nucleic acid sequence of at least one nucleic acid and at least one epigenetic alteration of the at least one nucleic acid in a sample of a subject. The sample is derived from a body fluid of the subject. The methods link the one or more modification(s) to a specific cell type.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: March 5, 2024
    Assignee: Siemens Healthcare GMBH
    Inventors: Carsten Dietrich, Andreas Emanuel Posch
  • Publication number: 20230386612
    Abstract: One or more example embodiments relates to a computer-implemented method for determining a similarity measure, the similarity measure describing a similarity between a first patient and a second patient. The method includes receiving a first patient data record, wherein the first patient data record is assigned to the first patient; receiving a second patient data record, wherein the second patient data record is assigned to the second patient; receiving or determining a medical ontology, wherein the medical ontology is independent of the first patient data record and the second patient data record; determining a patient ontology based on the medical ontology and at least one of the first patient data record or the second patient data record; and determining the similarity measure based on the patient ontology.
    Type: Application
    Filed: September 7, 2021
    Publication date: November 30, 2023
    Applicant: Siemens Healthcare GmbH
    Inventors: Oliver FRINGS, Carsten DIETRICH, Maximilian WEISS, Matthias SIEBERT, Mitchell JOBLIN
  • Patent number: 11705229
    Abstract: A method and a device are for exchanging information regarding the clinical implications genomic variations. In an embodiment, the method includes receiving login-data of a user; evaluating the login-data received; establishing an encrypted data connection to the user after the evaluating indicates a positive evaluation of the login-data; saving, upon receiving a dataset in a context of a genomic variation, the dataset received in a memory, context-related with the genomic variation; and evaluating, upon a user request being received and connected with a search query for the genomic variation, a set of datasets from the memory, the datasets being context-related with the genomic variation and the set including the datasets that the user is authorized to receive, and sending the set of datasets to the user.
    Type: Grant
    Filed: September 9, 2020
    Date of Patent: July 18, 2023
    Assignee: SIEMENS HEALTHCARE GMBH
    Inventors: Oliver Frings, Maximilian Wuerstle, Eugen Kubala, Dominik Neumann, Maximilian Weiss, Carsten Dietrich
  • Patent number: 11572593
    Abstract: The present invention relates to a method of selectively amplifying at least one nucleic acid sequence of at least one microorganism and/or virus in a sample of a subject, wherein k-mers 3 are applied that show a difference in frequency and/or context in the genome 2 of the at least one microorganism and/or virus compared to the genome of the subject 1.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: February 7, 2023
    Assignee: Siemens Aktiengesellschaft
    Inventors: Carsten Dietrich, Yiwei Huang, Mark Matzas, Andreas Emanuel Posch
  • Publication number: 20220275460
    Abstract: Disclosed are methods of predicting a radiotherapy success in a method of treating a lung cancer of a patient, the use of specific markers for predicting a radiotherapy success in a method of treating a lung cancer of a patient, a database comprising the markers, and a computer program product for use in such a method.
    Type: Application
    Filed: July 31, 2020
    Publication date: September 1, 2022
    Applicants: Siemens Healthcare GmbH, The Cleveland Clinic Foundation
    Inventors: Matthias SIEBERT, Carsten DIETRICH, Heike WEHNER, Jens-Christoph GEORGI, Mohamed ABAZEED, Andreas Emanuel POSCH, Andreas KAPPEL, Mark MATZAS
  • Publication number: 20210388427
    Abstract: The present invention relates to a method of characterizing a target DNA polynucleotide using rolling circle amplification (RCA) and a synthetic single guide RNA (sgRNA) to identify and cleave the WT version of the target DNA polynucleotide. Also provided are characterization steps based on the use of a transmembrane pore and a DNA translocase enzyme controlling the movement of the DNA polynucleotide through the transmembrane pore. Further envisaged is a kit comprising one or more oligonucleotides specific for at least a portion of the target DNA polynucleotide, an sgRNA specific for the WT version of the target DNA polynucleotide and an sgRNA-guided nucleic acid-binding protein.
    Type: Application
    Filed: October 29, 2019
    Publication date: December 16, 2021
    Inventors: Yiwei HUANG, Carsten DIETRICH, Tivadar MACH, Maximilian WÜRSTLE, Stefan PRAUSE
  • Publication number: 20210082546
    Abstract: A method and a device are for exchanging information regarding the clinical implications genomic variations. In an embodiment, the method includes receiving login-data of a user; evaluating the login-data received; establishing an encrypted data connection to the user after the evaluating indicates a positive evaluation of the login-data; saving, upon receiving a dataset in a context of a genomic variation, the dataset received in a memory, context-related with the genomic variation; and evaluating, upon a user request being received and connected with a search query for the genomic variation, a set of datasets from the memory, the datasets being context-related with the genomic variation and the set including the datasets that the user is authorized to receive, and sending the set of datasets to the user.
    Type: Application
    Filed: September 9, 2020
    Publication date: March 18, 2021
    Applicant: Siemens Healthcare GmbH
    Inventors: Oliver FRINGS, Maximilian WUERSTLE, Eugen KUBALA, Dominik NEUMANN, Maximilian WEISS, Carsten DIETRICH
  • Publication number: 20200002773
    Abstract: The present invention relates to methods of determining one or more modification(s) of the nucleic acid sequence of at least one nucleic acid and at least one epigenetic alteration of said at least one nucleic acid in a sample of a subject, wherein the sample is derived from a body fluid of the subject, in order to link the one or more modification to a specific cell type.
    Type: Application
    Filed: January 23, 2018
    Publication date: January 2, 2020
    Inventors: Carsten DIETRICH, Andreas Emanuel POSCH
  • Publication number: 20190345569
    Abstract: The present invention relates to a method of selectively amplifying at least one nucleic acid sequence of at least one microorganism and/or virus in a sample of a subject, wherein k-mers 3 are applied that show a difference in frequency and/or context in the genome 2 of the at least one microorganism and/or virus compared to the genome of the subject 1.
    Type: Application
    Filed: November 28, 2017
    Publication date: November 14, 2019
    Inventors: Carsten Dietrich, Yiwei Huang, Mark Matzas, Andreas Emanuel Posch
  • Patent number: 9294541
    Abstract: The present invention provides an improved method for correlation of session activities to a browser window in a client-server environment.
    Type: Grant
    Filed: September 18, 2013
    Date of Patent: March 22, 2016
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Carsten Dietrich, Matthias Seul, Stefan Walter
  • Publication number: 20140101236
    Abstract: The present invention provides an improved method for correlation of session activities to a browser window in a client-server environment.
    Type: Application
    Filed: September 18, 2013
    Publication date: April 10, 2014
    Applicant: International Business Machines Corporation
    Inventors: Carsten Dietrich, Matthias Seul, Stefan Walter